Literature DB >> 412921

Gold encephalopathy.

D L McAuley, B R Lecky, C J Earl.   

Abstract

Encephalopathy is described developing in a 42 year old man who was receiving gold treatment for rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412921      PMCID: PMC492888          DOI: 10.1136/jnnp.40.10.1021

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  3 in total

1.  [Nervous complications of gold therapy; survey of the neurological and psychiatric symptoms; results of treatment with BAL].

Authors:  L J ENDTZ
Journal:  Rev Neurol (Paris)       Date:  1958-09       Impact factor: 2.607

2.  Gold neuropathy.

Authors:  J C Walsh
Journal:  Neurology       Date:  1970-05       Impact factor: 9.910

3.  The lymphocyte transformation test and gold hypersensitivity.

Authors:  E J Denman; A M Denman
Journal:  Ann Rheum Dis       Date:  1968-11       Impact factor: 19.103

  3 in total
  2 in total

1.  Gold encephalopathy.

Authors:  M C Gulliford; N P Archard; W van't Hoff
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-08

2.  Acute disseminated encephalomyelitis as a complication of treatment with gold.

Authors:  M Cohen; C P Day; J L Day
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.